Identification d’une nouvelle cible thérapeutique du myélome multiple Inserm (salle de presse) - 11 Jan 2022 Identification d’une nouvelle cible thérapeutique du myélome multiple ... More
En Italie, les longues listes d'attente compliquent le traitement du myélome EURACTIV France - 03 May 2023 En Italie, les longues listes d'attente compliquent le traitement du myélome ... More
Le développement du myélome multiple - Comprendre le myélome multiple Institut National Du Cancer - 03 Oct 2018 Le développement du myélome multiple - Comprendre le myélome multiple ... More
En France, les nouveaux traitements du myélome permettent aux malades de vivre plus longtemps EURACTIV France - 28 Apr 2023 En France, les nouveaux traitements du myélome permettent aux malades de vivre plus longtemps ... More
Managing Cranial Nerve Impairment in Multiple Myeloma Following Cilta-cel Cancer Network - 01 May 2024 Managing Cranial Nerve Impairment in Multiple Myeloma Following Cilta-cel ... More
15th International Myeloma Foundation gala raises over $675K Myeloma Research News - 30 Apr 2024 15th International Myeloma Foundation gala raises over $675K ... More
Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high ... Nature - 22 Apr 2024 Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high ... ... More
Multiple Myeloma: What's a Therapy 'Line'? HealthTree - 29 Apr 2024 Multiple Myeloma: What's a Therapy 'Line'? ... More
European Commission Approves Cilta-Cel for R/R Myeloma After at Least 1 Prior Line of Therapy OncLive - 22 Apr 2024 European Commission Approves Cilta-Cel for R/R Myeloma After at Least 1 Prior Line of Therapy ... More
Daratumumab Plus Standard Therapy for Multiple Myeloma National Cancer Institute (.gov) - 19 Jan 2024 Daratumumab Plus Standard Therapy for Multiple Myeloma ... More
Cranial Nerve Palsy May Be Present After Cilta-Cel for Multiple Myeloma Oncology Nursing News - 27 Apr 2024 Cranial Nerve Palsy May Be Present After Cilta-Cel for Multiple Myeloma ... More
Dr Anderson on the FDA ODAC Decision Regarding Cilta-Cel in R/R Multiple Myeloma OncLive - 29 Apr 2024 Dr Anderson on the FDA ODAC Decision Regarding Cilta-Cel in R/R Multiple Myeloma ... More
Multi-dimensional scaling techniques unveiled gain1q&loss13q co-occurrence in Multiple Myeloma patients with ... Nature - 20 Feb 2024 Multi-dimensional scaling techniques unveiled gain1q&loss13q co-occurrence in Multiple Myeloma patients with ... ... More
Targeting DNA2 overcomes metabolic reprogramming in multiple myeloma Nature - 08 Feb 2024 Targeting DNA2 overcomes metabolic reprogramming in multiple myeloma ... More
Genomic and immune signatures predict clinical outcome in newly diagnosed multiple myeloma treated with ... Nature - 09 Nov 2023 Genomic and immune signatures predict clinical outcome in newly diagnosed multiple myeloma treated with ... ... More
Enhancing prognostic power in multiple myeloma using a plasma cell signature derived from single-cell RNA ... Nature - 06 Mar 2024 Enhancing prognostic power in multiple myeloma using a plasma cell signature derived from single-cell RNA ... ... More
The enduring neutrophil–stroma dance of multiple myeloma Nature - 10 Apr 2024 The enduring neutrophil–stroma dance of multiple myeloma ... More
In multiple myeloma, monthly treatment with zoledronic acid beyond two years offers sustained protection against ... Nature - 15 Apr 2024 In multiple myeloma, monthly treatment with zoledronic acid beyond two years offers sustained protection against ... ... More
Rheological properties of blood in multiple myeloma patients | Scientific Reports Nature - 21 Feb 2024 Rheological properties of blood in multiple myeloma patients | Scientific Reports ... More